The broad objective of the Research Education Component is to enrich and support the training of a diverse group of future research leaders in the study of Alzheimer's Disease (AD)-related disorders and brain aging. We will provide a varied range of experiences and activities so that participants gain an integrated perspective to perform critical and impactful studies of AD, related disorders, and brain aging. Use of an interdisciplinary scientific approach will be emphasized, and key features of sound and effective translational science will be highlighted. This component incorporates continuation of activities that were previously successfully implemented in the Outreach and Recruitment Core (formerly entitled the Education and Information Transfer Core). The plan includes travel awards, ethics training, encouragement of underrepresented minorities, mentoring opportunities, continuing education activities, exposure to scientific and public conferences, and information distribution by referencing the availability of the ADCC's resources and research opportunities. The Research Education Component will train, nurture, and support graduate students, postdoctoral fellows, junior faculty, and research associates by leveraging the interdisciplinary and collaborative nature of faculty in the ADCC and related programs. Opportunities will be provided for maximal career development and growth to lead to research independence.
The Specific Aims of the Research Education Component address the overarching goals to train, enrich, and provide opportunities for participants so that they develop into research leaders in the field of AD, related disorders, and brain aging.
Specific Aim 1 is to provide personalized mentorship and activities geared toward each participant's prior experience and current interests, leading to maximal career development and research independence.
Specific Aim 2 is to ensure exemplary training and exposure to the field of AD, related disorders, and brain research using a collaborative, interdisciplinary, and systems scientific approach that underscores the importance of translating basic science discoveries to impactful and real-world clinical outcomes.
Specific Aim 3 is to instruct and require adherence to the responsible conduct of research. The program faculty mentors associated with this component span numerous areas of expertise which, together, encompass an interdisciplinary, multifaceted systems approach to AD and aging. The breadth and depth of foci across laboratories allows a dynamic and systematic approach to mentoring, providing tremendous opportunities to personalize the mentee's research exposure based on their own goals and background. Moreover, the collaborative nature of our already established ADCC yields connectedness across program faculty, providing abundant opportunities for training in multiple dimensions and techniques directly applicable to understanding and intervening with AD and aging processes. Of critical importance to training researchers in the field of AD and aging, the Research Education Component builds on the many existing strengths of the ADCC to formalize training and education opportunities in a common geographical location, Arizona.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG019610-19
Application #
9528422
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
19
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Arizona State University-Tempe Campus
Department
Type
DUNS #
943360412
City
Tempe
State
AZ
Country
United States
Zip Code
85287
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Sabbagh, Marwan N; Shi, Jiong; Lee, Moonhee et al. (2018) Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer's disease dementia from normal controls: preliminary findings. BMC Neurol 18:155
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Walker, Douglas G; Tang, Tiffany M; Lue, Lih-Fen (2018) Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains. Exp Neurol 309:91-106
Cabrera, Erwin; Mathews, Paul; Mezhericher, Emiliya et al. (2018) A? truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition. Biochim Biophys Acta Mol Basis Dis 1864:208-225
Wu, Jianfeng; Zhang, Jie; Shi, Jie et al. (2018) HIPPOCAMPUS MORPHOMETRY STUDY ON PATHOLOGY-CONFIRMED ALZHEIMER'S DISEASE PATIENTS WITH SURFACE MULTIVARIATE MORPHOMETRY STATISTICS. Proc IEEE Int Symp Biomed Imaging 2018:1555-1559
Tariot, Pierre N; Lopera, Francisco; Langbaum, Jessica B et al. (2018) The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's diseas Alzheimers Dement (N Y) 4:150-160
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Beach, Thomas G; Serrano, Geidy E; Kremer, Thomas et al. (2018) Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4). J Neuropathol Exp Neurol 77:793-802

Showing the most recent 10 out of 794 publications